|Articles|April 1, 2016
- Applied Clinical Trials-04-01-2016
- Volume 25
- Issue 4
Applied Clinical Trials, April/May 2016 Issue (PDF)
Click the title above to open the Applied Clinical Trials April/May 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
EMA Releases New Advice on Human Trials for Cancer Drugsover 9 years ago
Number of Countries in Phase III Studies Remains Steadyover 9 years ago
Will EMA Rules Calm the Disclosure Debate?over 9 years ago
Acknowledging Cycle Time Impact from Protocol Amendmentsover 9 years ago
The Promise of Precision Medicineover 9 years ago
Value-Based Planning & Drug Development Productivityover 9 years ago
Overcoming Early Phase Oncology Challengesover 9 years ago
Imagining the Impossible: Immunity to CancerNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Komzifti for NPM1-Mutated AML Based on Positive Phase I/II KOMET-001 Trial Data
2
Proactive Planning is Key to Mitigating Study Rescue
3
Gilead’s Single-Tablet Bictegravi/Lenacapavir Regimen Shows Positive Phase III ARTISTRY-1 Results in Virologically Suppressed Adults with HIV
4
ACT Brief: Site Satisfaction, eSource Data Transfers, and Gilead HIV Trial Results
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
